Ivan Tornos

Chairman, President and Chief Executive Officer · Zimmer Biomet Holdings

Medical Devices

Ivan Tornos is chairman, president and chief executive officer of Zimmer Biomet Holdings. His medical technology career includes leadership at Johnson & Johnson, Baxter, Covidien, C.R. Bard and Becton Dickinson before joining Zimmer Biomet.

Last reviewed: Nov 4, 2026

Ivan Tornos

Chairman, President and Chief Executive Officer
Zimmer Biomet Holdings

Last Reviewed: November 4, 2026

Executive Summary

Ivan Tornos is chairman, president and chief executive officer of Zimmer Biomet Holdings. His medical technology career includes leadership at Johnson & Johnson, Baxter, Covidien, C.R. Bard and Becton Dickinson before joining Zimmer Biomet.

Career Highlights

  • Joined Zimmer Biomet as group president of Orthopedics on November 1, 2018.
  • Became chief operating officer in March 2021 and president and CEO on August 22, 2023.
  • Added the board chairmanship in May 2025.

Professional Journey

Tornos spent 11 years at Johnson & Johnson in roles of increasing responsibility before becoming international vice president of business development and strategy at Baxter International. He subsequently served as vice president and general manager for Covidien International’s Americas pharmaceutical and medical/imaging segments.

At C.R. Bard, he advanced through several leadership assignments, culminating in the presidency of its Europe, Middle East and Africa regions. He then became worldwide president of Becton Dickinson’s Global Urology, Medical and Critical Care division. These positions preceded his move to Zimmer Biomet.

Tornos joined Zimmer Biomet on November 1, 2018, as group president of Orthopedics. The newly created assignment encompassed large joints, sports medicine, extremities and trauma, alongside the Americas region. A year later, he became group president of Global Businesses and the Americas.

In March 2021, Tornos became chief operating officer. He oversaw global businesses and operations, clinical and medical education, research and development, and new product development, with regional oversight of the Americas and EMEA. On August 22, 2023, he succeeded Bryan Hanson as president and chief executive officer and joined the board.

Tornos became chairman in May 2025. Outside Zimmer Biomet, he serves on the boards of the Advanced Medical Technology Association and PHC Holdings, a global healthcare company.

Education

Tornos holds an MBA from the University of Miami and a BBA in finance and international marketing and management from the University of Georgia. His executive education includes Harvard Business School’s Advanced Management Program, leadership and management programs at Southern Methodist University’s Cox School of Business, and post-MBA marketing and finance study at Wharton.